Research - Broomfield, Colorado, United States
Virocyt was created in 2012 to focus on the commercialization of novel technologies that enable rapid quantification of viruses. Our goal is to provide the tools that deliver meaningful improvements to mission critical processes, such as vaccine manufacturing, protein expression, antiviral development and other settings where viruses play a significant role. In 2016, ViroCyt was acquired by and became a subsidiary of Sartorius, North America.
Outlook
Microsoft Office 365